Evidence map›Paper›PMID 42280184›Full record

ArticleMolecules (Basel, Switzerland)2026

Development of an Integrated CE-Cell-SELEX Strategy for Rational Selection of Human Bone Microvascular Endothelial Cell Aptamers.

Xinyu Fang, Wenting Pan, Jiefang Sun, Xiaojing Ding, Bing Shao, Jie Ouyang, Yiyang Dong

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xinyu FangCollege of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.
Wenting PanCollege of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.
Jiefang SunBeijing Research Center for Preventive Medicine, Beijing Center for Disease Prevention and Control, Beijing 100013, China.
Xiaojing DingBeijing Research Center for Preventive Medicine, Beijing Center for Disease Prevention and Control, Beijing 100013, China.
Bing ShaoBeijing Research Center for Preventive Medicine, Beijing Center for Disease Prevention and Control, Beijing 100013, China.
Jie OuyangCollege of Energy Environment and Safety Engineering & College of Carbon Metrology, China Jiliang University, Hangzhou 310018, China.
Yiyang DongCollege of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.ORCID 0000-0003-1752-3935

Funding

Zhejiang Provincial Natural Science Foundation ZCLQN25B0501
6 · The paper itself

Abstract

Capillary electrophoresis (CE) has proven to be an effective technique for aptamer selection. Here, we directly integrated the separation advantages of CE into a live-cell system, thereby establishing an integrated and highly efficient CE-Cell-SELEX screening model for bone microvascular endothelial cells (BMECs) without the need for negative selection. The selection progress was monitored through quantitative real-time fluorescence PCR (qRT-PCR) analysis, which yielded 7 candidate sequences from the amplified library after four rounds of selection. Flow cytometry analysis demonstrated that aptamer T-24 exhibited high affinity for BMECs, with a Kd of 111.86 ± 18.36 nM. Owing to its high affinity and specificity, coupled with its small molecular weight and non-immunogenicity, T-24 holds great potential as a biological probe for the identification and isolation of BMECs. Furthermore, molecular docking was performed by MOE 2022 software to validate the candidate sequences and assist in the identification process. The CE-Cell-SELEX method eliminates the need for negative screening and traditional elution, greatly reduces the screening cycle, and may provide a valuable reference system for the early diagnosis and precise treatment of femoral head ischemia.

Indexed as

Aptamers, NucleotideBone and BonesEndothelial CellsMicrovesselsSELEX Aptamer TechniqueElectrophoresis, CapillaryFlow CytometryHumansMolecular Docking SimulationAptamers, Nucleotideaptamerbone microvascular endothelial cellsCE-Cell-SELEX

Identifiers

PMID42280184
PMCPMC13258299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.